Instrument Inactif

Communiqués BIO-TECHNE Corp Nasdaq

Actions

US8783771004

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

11/06	Transcript : Bio-Techne Corporation Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 09:20 AM
06/06	Transcript : Bio-Techne Corporation Presents at Jefferies 2024 Global Healthcare Conference, Jun-06-2024 09:30 AM

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES	03/06	AQ
BIO-TECHNE TO HIGHLIGHT MULTIPLE APPLICATIONS OF THE MAURICEFLEX SYSTEM AT THE ANNUAL ASMS CONFERENCE	31/05	AQ
BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES	31/05	PR
BIO-TECHNE CORPORATION - SCALEREADY ANNOUNCES $20 MILLION G-REX GRANT PROGRAM FOR THE ADVANCEMENT OF CELL AND GENE THERAPY DEVELOPMENT AND MANUFACTURING	30/05	AQ
BIO-TECHNE TO HIGHLIGHT MULTIPLE APPLICATIONS OF THE MauriceFlex™ SYSTEM AT THE ANNUAL ASMS CONFERENCE	30/05	PR
ScaleReady Announces $20 Million G-Rex® Grant Program for the Advancement of Cell and Gene Therapy (CGT) Development and Manufacturing	29/05	PR
BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE	23/05	PR
BIO-TECHNE HIGHLIGHTS RECENTLY ANNOUNCED TOP-LINE BIOMARKER DATA FROM PARTNER, REGULUS THERAPEUTICS, USING THE COMPANY'S PROPRIETARY TECHNOLOGY	22/05	PR
BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024	08/05	PR
BIO-TECHNE DECLARES DIVIDEND	01/05	PR
BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS	01/05	PR
BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS	30/04	PR
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC	29/04	PR
BIO-TECHNE AND NOVOMOL-Dx ANNOUNCE POINT-OF-CARE OCULAR BIOMARKER ASSAY	26/04	PR
BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS	23/04	PR
BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS	10/04	PR
BIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY	08/04	PR
BIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS	01/04	PR
BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES	28/03	PR
BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA	25/03	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués BIO-TECHNE Corp Nasdaq

Actions

US8783771004

Communiqués

Filtres